Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK

Cessation rate of anti-osteoporosis treatments and risk factors in Spanish primary care settings: a population-based cohort analysis

(2017) Elisa Martín-Merino et al.   Archives of Osteoporosis

Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study

(2015) C. Carbonell-Abella et al.   CALCIFIED TISSUE INTERNATIONAL

Ranélate de strontium (Protelos®) : effets indésirables rapportés en France

(2011) Annie-Pierre Jonville-Bera et al.   PRESSE MEDICALE

Incidence of Venous Thromboembolism in Users of Strontium Ranelate

(2010) Vicki Osborne et al.   DRUG SAFETY

Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length

(2009) Helga Gardarsdottir et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database

(2009) G. Breart et al.   OSTEOPOROSIS INTERNATIONAL

Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions

(2008) Anthony Grosso et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY